Natural-Killer-like B Cells Display the Phenotypic and Functional Characteristics of Conventional B Cells.

Yann M. Kerdiles,1,8,* Francisca F. Almeida,2,3,8 Thornton Thompson,4,8 Michael Chopin,2,3,8 Margaux Vienne,1 Pierre Bruhns,5,6 Nicholas D. Huntington,2,3 David H. Raulet,4,9 Stephen L. Nutt,2,3,9 Gabrielle T. Belz,2,3,9 and Eric Vivier1,7,9 1Centre d’Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, Marseille, France 2Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia 3Department of Medical Biology, University of Melbourne, VIC 3010 Australia 4Department of Molecular and Cell Biology and Immunotherapeutics and Vaccine Research Initiative, University of California, Berkeley, Berkeley, CA 94720-3200 USA 5Institut Pasteur, Department of Immunology, Unit of Antibodies in Therapy and Pathology, Paris, France 6INSERM, U1222, Paris, France 7Service d’Immunologie, Hôpital de la Timone, Assistance Publique – Hôpitaux de Marseille, Marseille, France 8These authors contributed equally 9Senior author *Correspondence: [email protected] http://dx.doi.org/10.1016/j.immuni.2017.07.026